364 related articles for article (PubMed ID: 16768769)
21. Factors associated with actual long-term survival following soft tissue sarcoma pulmonary metastasectomy.
Smith R; Pak Y; Kraybill W; Kane JM
Eur J Surg Oncol; 2009 Apr; 35(4):356-61. PubMed ID: 18294807
[TBL] [Abstract][Full Text] [Related]
22. Intraoperative electron-beam therapy for primary and recurrent retroperitoneal soft-tissue sarcoma.
Krempien R; Roeder F; Oertel S; Weitz J; Hensley FW; Timke C; Funk A; Lindel K; Harms W; Buchler MW; Debus J; Treiber M
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):773-9. PubMed ID: 16682152
[TBL] [Abstract][Full Text] [Related]
23. [Retroperitoneal sarcoma. Therapy and course].
Roggo A; Weder W; Mauch JY; Schlumpf R; Largiadèr F
Helv Chir Acta; 1993 Sep; 60(1-2):117-20. PubMed ID: 8226037
[TBL] [Abstract][Full Text] [Related]
24. [Retroperitoneal sarcoma. Treatment of 51 patients].
Lev-Chelouche D; Abu-Abeid S; Gutman M; Kluger Y; Michovitch M; Meller I; Inbar M; Klausner JM
Harefuah; 1999 Apr; 136(8):589-93, 660. PubMed ID: 10955061
[TBL] [Abstract][Full Text] [Related]
25. Long-term prognosis of primary retroperitoneal soft tissue sarcoma.
van Dalen T; Plooij JM; van Coevorden F; van Geel AN; Hoekstra HJ; Albus-Lutter Ch; Slootweg PJ; Hennipman A; Dutch Soft Tissue Sarcoma Group
Eur J Surg Oncol; 2007 Mar; 33(2):234-8. PubMed ID: 17081725
[TBL] [Abstract][Full Text] [Related]
26. Surgery combined with intraoperative brachytherapy in the treatment of retroperitoneal sarcomas.
Dziewirski W; Rutkowski P; Nowecki ZI; Sałamacha M; Morysiński T; Kulik A; Kawczyńska M; Kasprowicz A; Lyczek J; Ruka W
Ann Surg Oncol; 2006 Feb; 13(2):245-52. PubMed ID: 16411144
[TBL] [Abstract][Full Text] [Related]
27. Outcome after surgical resections of recurrent chest wall sarcomas.
Wouters MW; van Geel AN; Nieuwenhuis L; van Tinteren H; Verhoef C; van Coevorden F; Klomp HM
J Clin Oncol; 2008 Nov; 26(31):5113-8. PubMed ID: 18794540
[TBL] [Abstract][Full Text] [Related]
28. Multifocality in retroperitoneal sarcoma: a prognostic factor critical to surgical decision-making.
Anaya DA; Lahat G; Liu J; Xing Y; Cormier JN; Pisters PW; Lev DC; Pollock RE
Ann Surg; 2009 Jan; 249(1):137-42. PubMed ID: 19106689
[TBL] [Abstract][Full Text] [Related]
29. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate.
Wang AY; Ahmad NA; Zaidman JS; Brensinger CM; Lewis JD; Long WB; Kochman ML; Ginsberg GG
Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483
[TBL] [Abstract][Full Text] [Related]
30. Retroperitoneal sarcoma: the University of Florida experience.
Kilkenny JW; Bland KI; Copeland EM
J Am Coll Surg; 1996 Apr; 182(4):329-39. PubMed ID: 8605556
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of a clinically applicable post-surgical classification system for primary retroperitoneal soft-tissue sarcoma.
van Dalen T; Hennipman A; Van Coevorden F; Hoekstra HJ; van Geel BN; Slootweg P; Lutter CF; Brennan MF; Singer S
Ann Surg Oncol; 2004 May; 11(5):483-90. PubMed ID: 15078637
[TBL] [Abstract][Full Text] [Related]
32. Outcomes in a series of 103 retroperitoneal sarcomas.
Pierie JP; Betensky RA; Choudry U; Willett CG; Souba WW; Ott MJ
Eur J Surg Oncol; 2006 Dec; 32(10):1235-41. PubMed ID: 16919908
[TBL] [Abstract][Full Text] [Related]
33. Aggressive surgical treatment of retroperitoneal sarcoma: long-term experience of a single institution.
Erzen D; Novak J; Spiler M; Sencar M
Surg Technol Int; 2007; 16():97-106. PubMed ID: 17429776
[TBL] [Abstract][Full Text] [Related]
34. Retroperitoneal sarcomas in children: outcomes from an institution.
Pham TH; Iqbal CW; Zarroug AE; Donohue JH; Moir C
J Pediatr Surg; 2007 May; 42(5):829-33. PubMed ID: 17502193
[TBL] [Abstract][Full Text] [Related]
35. A contemporary large single-institution evaluation of resected retroperitoneal sarcoma.
Bremjit PJ; Jones RL; Chai X; Kane G; Rodler ET; Loggers ET; Pollack SM; Pillarisetty VG; Mann GN
Ann Surg Oncol; 2014 Jul; 21(7):2150-8. PubMed ID: 24615180
[TBL] [Abstract][Full Text] [Related]
36. Establishing prognosis in retroperitoneal sarcoma: a new histology-based paradigm.
Anaya DA; Lahat G; Wang X; Xiao L; Tuvin D; Pisters PW; Lev DC; Pollock RE
Ann Surg Oncol; 2009 Mar; 16(3):667-75. PubMed ID: 19101765
[TBL] [Abstract][Full Text] [Related]
37. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control.
Bonvalot S; Rivoire M; Castaing M; Stoeckle E; Le Cesne A; Blay JY; Laplanche A
J Clin Oncol; 2009 Jan; 27(1):31-7. PubMed ID: 19047280
[TBL] [Abstract][Full Text] [Related]
38. Impact of histology on survival in retroperitoneal sarcomas.
Brown RE; St Hill CR; Greene QJ; Farmer RW; Reuter NP; Callendar GG; Martin RC; McMasters KM; Scoggins CR
Am J Surg; 2011 Dec; 202(6):748-52; discussion 752-3. PubMed ID: 22030405
[TBL] [Abstract][Full Text] [Related]
39. Percutaneous core needle biopsy in retroperitoneal sarcomas does not influence local recurrence or overall survival.
Wilkinson MJ; Martin JL; Khan AA; Hayes AJ; Thomas JM; Strauss DC
Ann Surg Oncol; 2015 Mar; 22(3):853-8. PubMed ID: 25190132
[TBL] [Abstract][Full Text] [Related]
40. Carbon ion radiotherapy for unresectable retroperitoneal sarcomas.
Serizawa I; Kagei K; Kamada T; Imai R; Sugahara S; Okada T; Tsuji H; Ito H; Tsujii H
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1105-10. PubMed ID: 19467578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
